Aortic stenosis grading assigns each patient to one of four stages (A, B, C, D) using three numbers: peak aortic jet velocity, mean transvalvular pressure gradient, and aortic valve area. Mild disease starts at a velocity of 2.0 m/s, moderate at 3.0 m/s, and severe at 4.0 m/s, which corresponds to a mean gradient of 40 mmHg and a valve area of 1.0 cm² or less. Stage D means severe stenosis plus symptoms or ventricular dysfunction, and that combination is what triggers valve replacement. No single number decides the grade; the grade comes from how the numbers fit together.
The hemodynamic mechanism behind every grade boundary
A stenotic aortic valve behaves like a fixed orifice in a pipe. As the opening shrinks, the left ventricle must generate a higher pressure to push the same stroke volume through it, and the velocity of the jet rises with the square root of that pressure difference. This is why peak velocity is the anchor measurement of aortic stenosis grading: it is flow-dependent, but its relationship to gradient is physical rather than arbitrary.
The continuity equation explains the valve area estimate. Flow through the left ventricular outflow tract must equal flow through the valve, so valve area equals outflow tract area times the velocity ratio. That ratio, called the dimensionless index, divides outflow tract velocity by aortic jet velocity. A dimensionless index below 0.25 indicates severe stenosis independent of body size, which matters for small patients whose absolute valve area looks reassuring.
In plain terms: velocity measures how hard the ventricle is pushing, and valve area estimates how small the hole has become. When the two disagree, the disagreement itself is diagnostic information.
Aortic stenosis is not just a rigid hole. The leaflets calcify, the annulus stiffens, and the ventricle remodels with concentric hypertrophy. That hypertrophy raises wall stress but preserves ejection fraction for years, which is why a normal ejection fraction does not rule out advanced disease. The 2020 ACC/AHA valve guideline formalized the stage-based grading system used below, building on the 2014 version that first replaced severity-only labels with stages.
The four stages of aortic stenosis grading
Staging combines anatomy, hemodynamics, symptoms, and ventricular response. Two patients can share a 4.2 m/s velocity and land in different stages depending on whether they have symptoms or a failing ventricle.
| Stage | Label | Valve anatomy | Velocity | Mean gradient | Valve area | Symptoms or LV response |
|---|---|---|---|---|---|---|
| A | At risk | Bicuspid valve, sclerosis | Less than 2.0 m/s | Not applicable | Normal | None |
| B | Progressive | Mild to moderate calcification | 2.0 to 3.9 m/s | Under 40 mmHg | Over 1.0 cm² | None |
| C1 | Asymptomatic severe | Severe calcification | 4.0 m/s or more | 40 mmHg or more | 1.0 cm² or less | None, normal EF |
| C2 | Asymptomatic severe with LV dysfunction | Severe calcification | 4.0 m/s or more | 40 mmHg or more | 1.0 cm² or less | EF under 50 percent |
| D1 | Symptomatic severe high-gradient | Severe calcification | 4.0 m/s or more | 40 mmHg or more | 1.0 cm² or less | Angina, syncope, or dyspnea |
| D2 | Symptomatic severe low-flow low-gradient | Severe calcification | Under 4.0 m/s | Under 40 mmHg | 1.0 cm² or less | Symptoms with EF under 50 percent |
| D3 | Symptomatic severe low-gradient normal EF | Severe calcification | Under 4.0 m/s | Under 40 mmHg | 1.0 cm² or less | Symptoms with EF 50 percent or more |
The severity bands inside Stage B are worth memorizing. Mild is 2.0 to 2.9 m/s with a mean gradient under 20 mmHg. Moderate is 3.0 to 3.9 m/s with a gradient of 20 to 39 mmHg. Severe begins at 4.0 m/s and 40 mmHg with an area at or below 1.0 cm². Very severe is often defined as 5.0 m/s or more.
Stage D is where intervention lives. Stage C is surveillance. Stage A and B are risk management. That triage logic is the entire practical purpose of aortic stenosis grading.
Reading the numbers: echocardiography cutoffs and their reconciliation
The three severity thresholds are not independent tests. They are three views of one hemodynamic state, and guideline writers set them so a typical patient crosses all three at roughly the same point. A velocity of 4.0 m/s, a mean gradient of 40 mmHg, and a valve area of 1.0 cm² describe the same severe lesion in a normal-flow patient.
That reconciliation breaks when flow is abnormal, which is the central caveat of modern grading. In low-flow states, a severely narrowed valve can produce a velocity of only 3.2 m/s and a gradient of 28 mmHg while the true area is 0.7 cm². The lesion is severe, but the numbers understate it. Conversely, high-flow states such as anemia, sepsis, or thyrotoxicosis can push a moderate valve past 4.0 m/s and create a false severe label.
The practical rule: read velocity and gradient as flow-dependent, and read valve area as geometry. When they conflict, measure flow directly.
The continuity equation needs a careful outflow tract diameter. A 1 mm error in a 20 mm tract diameter changes the calculated area by roughly 10 percent, because area scales with the square of the radius. That is why experienced sonographers average multiple measurements.
Low-flow low-gradient patterns and dobutamine stress
Low-flow low-gradient aortic stenosis is the hardest pattern to grade, and it splits into two phenotypes that look similar on a resting echo but behave very differently.
Classical low-flow low-gradient disease has a reduced ejection fraction under 50 percent and a stroke volume index under 35 mL/m². The ventricle is failing, so it cannot generate a high gradient. True severity is confirmed with low-dose dobutamine stress echocardiography: if the velocity rises above 4.0 m/s at any dose, the stenosis is genuinely severe and contractile reserve is present. Absence of contractile reserve (stroke volume rising less than 20 percent) carries a poor prognosis.
Paradoxical low-flow low-gradient disease has a preserved ejection fraction of 50 percent or more but a small, hypertrophied ventricle that cannot fill adequately, yielding a stroke volume index under 35 mL/m². This pattern is more common in older women with small body size and severe concentric hypertrophy. Aortic valve calcium scoring by CT resolves it: a score above 1,300 Agatston units in women or 2,000 in men supports severe stenosis even when the gradient is only 30 mmHg.
Here is the non-obvious correction. Paradoxical low-flow disease was once dismissed as measurement noise. Contemporary data show it carries a prognosis close to classical severe stenosis, and the 2020 ACC/AHA guideline recognizes it as a legitimate pathway to intervention when symptoms are present.
Aortic stenosis progression timeline
Progression is not linear, and the rate depends heavily on valve morphology. Bicuspid valves calcify earlier and faster than tricuspid valves. This timeline reflects typical median rates and is meant for planning surveillance intervals, not for predicting an individual patient.
| Time point | Typical finding | Median velocity | Practical implication |
|---|---|---|---|
| Baseline | Sclerotic or mildly stenotic valve | 2.0 to 2.5 m/s | Establish reference echo, assess morphology |
| Year 1 to 2 | Slow early progression | Rise of 0.1 to 0.3 m/s per year | Echo every 3 to 5 years if mild |
| Year 3 to 5 | Moderate stenosis develops | 3.0 to 3.9 m/s | Echo every 1 to 2 years |
| Year 5 to 8 | Severe stenosis in many patients | 4.0 m/s or more | Echo every 6 to 12 months |
| Symptom onset | Angina, syncope, or dyspnea | Any severe value | Urgent cardiology referral |
| Untreated symptomatic severe | High event risk | Not applicable | Average survival 2 to 3 years without intervention |
Mean gradient rises about 7 mmHg per year and valve area falls about 0.1 cm² per year in the average patient with severe disease, but individual rates scatter widely. Rapid progressors, defined as a velocity increase of 0.3 m/s or more per year, need closer follow-up and earlier discussion of intervention.
Symptoms, red flags, and why they change the grade
Symptoms reclassify a patient from Stage C to Stage D, and that single reclassification is the most consequential step in aortic stenosis grading. Once typical symptoms appear in severe stenosis, the average survival without valve replacement is 2 to 3 years. That is the number that justifies intervening even in a patient who looks well otherwise.
Atypical presentations hide the transition. Reduced exercise tolerance attributed to aging, a new decline in activity level, or unexplained fatigue can be the first sign. Exercise stress testing is useful in asymptomatic patients who seem to be limiting activity, but it is contraindicated in patients with symptoms at rest.
These are the red flags that demand prompt evaluation:
- Exertional syncope or near-syncope, which can occur with exertion and carries a high sudden-death risk.
- New angina in a patient with known severe stenosis, even without coronary disease.
- Unexplained dyspnea on exertion or a drop in functional capacity.
- A fall in ejection fraction below 50 percent on surveillance echo.
- A rapid rise in peak velocity of 0.3 m/s or more within one year.
- Aortic valve area crossing below 1.0 cm² with a gradient approaching 40 mmHg in a previously moderate case.
Choosing the right imaging test: echo versus CT versus catheterization
Transthoracic echocardiography is the first-line and usually sufficient test. The other modalities answer specific questions that echo cannot. The comparison below reflects the practical trade-offs rather than a rigid hierarchy.
| Modality | Best use | Strength | Limitation |
|---|---|---|---|
| Transthoracic echo | Initial grading of every patient | Velocity, gradient, area, and LV function in one study | Flow-dependent, operator-dependent |
| Dobutamine stress echo | Classical low-flow low-gradient disease | Reveals contractile reserve and true severity | Risk of arrhythmia, requires monitoring |
| Cardiac CT calcium score | Ambiguous low-gradient cases | Flow-independent, reproducible | Radiation dose, no hemodynamics |
| Cardiac MRI | Borderline cases, ventricular assessment | Precise volumes and fibrosis imaging | Cost and availability |
| Invasive catheterization | Discrepant echo and clinical picture | Direct hemodynamic measurement | Invasive, not a screening tool |
Invasive catheterization is reserved for cases where echo and the clinical picture disagree, or when coronary angiography is needed before surgery. It is not a routine grading step.
What to actually do with a grade
The grade only matters if it drives an action. Stage A patients need blood pressure control and periodic auscultation, with a repeat echo every 3 to 5 years. Stage B patients need echo intervals of 1 to 2 years for moderate disease and closer follow-up if progression is rapid. Stage C patients need echo every 6 to 12 months and a clear conversation about the timing of intervention. Stage D patients need referral to a heart valve team.
Several concrete steps improve outcomes:
- Confirm the grade with a second study when the numbers are borderline or when symptoms and hemodynamics disagree.
- Track the trend, not just the current value, because a velocity rising from 3.4 to 3.9 m/s in one year matters more than a stable 3.8 m/s.
- Screen for high-flow confounders such as anemia or infection before accepting a severe label.
- Address modifiable risk factors including hypertension and lipid status, though no therapy has been proven to halt calcification.
- Discuss the choice between surgical and transcatheter replacement once intervention is indicated, since the decision depends on age, anatomy, and surgical risk.
Limitations of grading and the state of the evidence
Grading schemes are decision aids, not verdicts. A patient with a velocity of 3.9 m/s and a gradient of 39 mmHg sits just below every threshold for severe disease, yet a 1 mmHg difference is not a biological boundary. Clinicians should treat thresholds as transition zones and weigh the whole picture.
The evidence base has gaps. No medical therapy has been shown in a randomized trial to slow calcific progression, so the surveillance interval is a judgment call rather than a proven prescription. Aortic valve calcium score cutoffs vary between published cohorts, and the 1,300 and 2,000 Agatston thresholds are the most widely used but not universal.
Finally, grading in special populations remains difficult. Patients with small body size, women with paradoxical low-flow physiology, and those with mixed valve disease all fall outside the clean thresholds. When the numbers and the patient disagree, trust the patient and get more data.